Axogen, Inc. financial data

Symbol
AXGN on Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
Location
13631 Progress Blvd., Suite 400, Alachua, FL
State of incorporation
MN
Fiscal year end
December 31
Former names
LECTEC CORP /MN/ (to 9/29/2011)
Latest financial report
10-K - Q4 2024 - Feb 26, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 346 % +1.11%
Quick Ratio 118 % +38.7%
Debt-to-equity 96.7 % -2.42%
Return On Equity -10.2 % +54.6%
Return On Assets -5.17 % +54.1%
Operating Margin -1.75 % +87%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 44.3M shares +1.46%
Common Stock, Shares, Outstanding 44.1M shares +2.38%
Entity Public Float 187M USD -40.6%
Common Stock, Value, Issued 441K USD +2.32%
Weighted Average Number of Shares Outstanding, Basic 44.3M shares +3.22%
Weighted Average Number of Shares Outstanding, Diluted 44.3M shares +3.22%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 187M USD +17.8%
Research and Development Expense 27.8M USD +1.57%
Selling and Marketing Expense 78.5M USD +1.14%
General and Administrative Expense 39M USD +1.62%
Costs and Expenses 145M USD +1.35%
Operating Income (Loss) -3.29M USD +84.7%
Nonoperating Income (Expense) -6.68M USD -2529%
Net Income (Loss) Attributable to Parent -9.96M USD +54.1%
Earnings Per Share, Basic -0.23 USD/shares +54.9%
Earnings Per Share, Diluted -0.23 USD/shares +54.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 27.6M USD -11.2%
Accounts Receivable, after Allowance for Credit Loss, Current 24.1M USD -4.14%
Inventory, Net 33.2M USD +44.1%
Assets, Current 99.2M USD +12.7%
Operating Lease, Right-of-Use Asset 14.3M USD -8.33%
Intangible Assets, Net (Excluding Goodwill) 5.58M USD +23.1%
Assets 204M USD +3.51%
Accounts Payable, Current 8.01M USD -32%
Liabilities, Current 30.6M USD +0.59%
Operating Lease, Liability, Noncurrent 19.2M USD -9.15%
Other Liabilities, Noncurrent 94K USD
Liabilities 99.8M USD -1.33%
Retained Earnings (Accumulated Deficit) -291M USD -3.54%
Stockholders' Equity Attributable to Parent 104M USD +8.62%
Liabilities and Equity 204M USD +3.51%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -12.3M USD -65.2%
Net Cash Provided by (Used in) Financing Activities 204K USD -67.8%
Net Cash Provided by (Used in) Investing Activities -3.25M USD -314%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 44.1M shares +2.38%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -15.3M USD -102%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 33.6M USD -9.38%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.66M USD
Deferred Tax Assets, Valuation Allowance 61.5M USD +0.52%
Deferred Tax Assets, Gross 66.3M USD +0.15%
Depreciation 6.47M USD +53.3%
Payments to Acquire Property, Plant, and Equipment 924K USD -78.5%
Operating Lease, Liability, Current 1.96M USD +27.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure 0%
Deferred Tax Assets, Operating Loss Carryforwards 37.3M USD -9.97%
Amortization of Intangible Assets 267K USD -2.2%
Depreciation, Depletion and Amortization 1.52M USD +114%
Share-based Payment Arrangement, Expense 5M USD +5.41%
Interest Expense 5.15M USD +1699%